2篇
您的检索式：作者名="Anastasios Athanasopoulos"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Sildenafil versus continuous positive airway pressure for erectile dysfunction in men with obstructive sleep apnea: a comparat-ive study of their efficacy and safety and the patient's satisfaction with treatment显示文摘瞄准:与妨碍的睡觉呼吸暂停(OSA ) 在并发的可勃起的机能障碍(编辑) 的治疗估计 sildenafil 和连续积极航线压力(CPAP ) 的功效,并且在病人和他们的 partners.Methods 计量治疗满足的水平:四十个人与 sildenafil 被对待 12 个星期 100 mg (20 个人) 或 CPAP 在夜间期间睡觉(20 个人) 。治疗功效被成功的交际尝试的率估计,并且对治疗的满足被病人估计“并且搭挡”询问 1 个可勃起的机能障碍的答案治疗盘点满足。结果:Undersildenafil, 249 中的 128 个(51.4%) 交际尝试是成功的;在 CPAP 下面,(26.9%) 193 中的 51 个尝试是成功的(~ cP <
0.001 ) 。可勃起的功能在两个组被改进。Aftersildenafil 和 CPAP 治疗,为可勃起的功能领域的吝啬的国际索引获得 were14.3 并且 10.8,分别地(~ bP = 0.025 ) ,与 7.8 和 7 相比在基线分别地。CPAPand sildenafil 很好被容忍。在 CPAP 和短暂头疼下面的鼻音干的分散的事件并且在 sildenafil 下面涌出不是重要的。百分之五十个病人对待 withsildenafil, 25% 与治疗对 CPAP 满意,并且他们的搭挡同等地满足。为在 sildenafil 下面的病人和搭挡的满足分数比在 CPAP 下面的那些优异(~ cP <
0.002 ) 。结论:两 sildenafil 100 mg 和 CPAP,独立使用,有积极治疗学的影响,但是 sildenafil 是优异的。病人和他们的搭挡是然而为编辑的治疗对 sildenafil 满意的更多,因为不满足的人的高比例,搭挡,新治疗学的代理人或二个方法的联合必须进一步被学习。 | Petros Perimenis Kyriakos Karkoulias Angelis Konstantinopoulos Paraskevi P. Perimeni George Katsenis Anastasios Athanasopoulos Konstantinos Spyropoulos | 2007 | Asian Journal of Andrology2007，9，2： | 3 |
| 2 | Desmopressin for the treatment of female storage lower urinary tract symptoms显示文摘Female storage lower urinary tract symptoms are prevalent and bothersome. They are usually attributed to an overactive bladder and treated with antimuscarinics. Nevertheless, failure of conventional treatment to alleviate nocturia in particular and epidemiological data suggesting that nocturnal polyuria is the only or a contributing factor to nocturia, has attracted interest in decreasing nighttime urine production as a method of managing nocturia. A reduction in urine production could also, at least temporarily, delay daytime storage symptoms by delaying bladder filling. Therefore, desmopressin, the synthetic analogue or naturally occurring antidiuretic hormone, could have a role in the management of female frequency, urgency and urgency incontinence. This work aims to review data on the use of desmopressin in females with storage symptoms. Available evidence indicates that desmopressin is efficacious in reducing nighttime urine production and episodes of nocturia, resulting in fewer sleep interruptions. This translates into improved quality of life. Desmopressin is also effective in postponing micturition, urgency and incontinence for several hours after being taken on demand. The tolerability profile of desmopressin is good and significantly improved compared to historical figures due to the introduction of new oral formulations, tailoring the dose according to gender and age and adhering to instructions for fluid restriction before administration. The incidence of hyponatremia, desmopressin's most important side-effect, is less than 3% in recent trials. The efficacy of desmopressin, combined with its improved safety profile, makes it an interesting method for treating female storage lower urinary tract symptoms. | Konstantinos Giannitsas Anastasios Athanasopoulos | 2014 | World Journal of Obstetrics and Gynecology2014，3，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员